Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Mr. Hongzhe Jiang |
IPO Date | Nov. 25, 2022 |
Location | |
Headquarters | No. 633, Taiwan Avenue |
Employees | 19 |
Sector | Health Care |
Industries |
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email